-
-
-
-
-
-
-
Abivax (ABVX) PT Raised to $155 at Truist Securities
-
-
-
-
-
-
-
Abivax (ABVX) Halted, News Pending
-
-
-
-
-
-
-
Jefferies Downgrades Abivax (ABVX) to Hold
-
-
-
-
-
-
-
Truist on Abivax (ABVX): 'We continue to see a robust opportunity'
-
-
-
-
-
-
-
Guggenheim Reiterates Abivax (ABVX) at Buy, 'ABVX remains as our Best Idea'
-
-
-
-
-
-
-
Abivax secures 22 abstracts on inflammatory bowel disease drug at ECCO 2026
-
-
-
-
-
-
-
Abivax presents ulcerative colitis drug data at gastroenterology meeting
-
483,120 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


